124 related articles for article (PubMed ID: 17371231)
21. BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.
Glassford J; Soeiro I; Skarell SM; Banerji L; Holman M; Klaus GG; Kadowaki T; Koyasu S; Lam EW
Oncogene; 2003 Apr; 22(15):2248-59. PubMed ID: 12700661
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the spinal phosphoinositide 3-kinase exacerbates morphine withdrawal response.
Yang L; Zhu CJ; Cao JL; Zeng YM
Neurosci Lett; 2006 Aug; 404(1-2):237-41. PubMed ID: 16806705
[TBL] [Abstract][Full Text] [Related]
23. Lipids on the move: phosphoinositide 3-kinases in leukocyte function.
Wymann MP; Sozzani S; Altruda F; Mantovani A; Hirsch E
Immunol Today; 2000 Jun; 21(6):260-4. PubMed ID: 10939787
[No Abstract] [Full Text] [Related]
24. A robust screen for inhibitors and enhancers of phosphoinositide-3 kinase (PI3K) activities by ratiometric fluorescence superquenching.
Stankewicz C; Rininsland FH
J Biomol Screen; 2006 Jun; 11(4):413-22. PubMed ID: 16490774
[TBL] [Abstract][Full Text] [Related]
25. Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritis.
Foey A; Green P; Foxwell B; Feldmann M; Brennan F
Arthritis Res; 2002; 4(1):64-70. PubMed ID: 11879539
[TBL] [Abstract][Full Text] [Related]
26. LY-294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] affects calcium signaling in airway smooth muscle cells independently of phosphoinositide 3-kinase inhibition.
Tolloczko B; Turkewitsch P; Al-Chalabi M; Martin JG
J Pharmacol Exp Ther; 2004 Nov; 311(2):787-93. PubMed ID: 15194708
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor 2 uses PLC-gamma1 for cell proliferation and PI3-kinase for alteration of cell shape and cell proliferation in corneal endothelial cells.
Kay EP; Park SY; Ko MK; Lee SC
Mol Vis; 1998 Oct; 4():22. PubMed ID: 9808840
[TBL] [Abstract][Full Text] [Related]
28. Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro.
Phu T; Haeryfar SM; Musgrave BL; Hoskin DW
J Leukoc Biol; 2001 May; 69(5):803-14. PubMed ID: 11358990
[TBL] [Abstract][Full Text] [Related]
29. Comparative effect of two pan-class I PI3K inhibitors used as anticancer drugs on human T cell function.
Blanco B; Herrero-Sánchez C; Rodríguez-Serrano C; Sánchez-Barba M; Del Cañizo MC
Int Immunopharmacol; 2015 Sep; 28(1):675-85. PubMed ID: 26256696
[TBL] [Abstract][Full Text] [Related]
30. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
[TBL] [Abstract][Full Text] [Related]
31. Trypanosoma cruzi: phosphatidylinositol 3-kinase and protein kinase B activation is associated with parasite invasion.
Wilkowsky SE; Barbieri MA; Stahl P; Isola EL
Exp Cell Res; 2001 Apr; 264(2):211-8. PubMed ID: 11262178
[TBL] [Abstract][Full Text] [Related]
32. Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion.
Barber DF; Bartolomé A; Hernandez C; Flores JM; Fernandez-Arias C; Rodríguez-Borlado L; Hirsch E; Wymann M; Balomenos D; Carrera AC
J Immunol; 2006 Jan; 176(1):589-93. PubMed ID: 16365454
[TBL] [Abstract][Full Text] [Related]
33. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
[TBL] [Abstract][Full Text] [Related]
34. SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation.
Poser S; Impey S; Trinh K; Xia Z; Storm DR
EMBO J; 2000 Sep; 19(18):4955-66. PubMed ID: 10990459
[TBL] [Abstract][Full Text] [Related]
35. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.
Brennan FM; Hayes AL; Ciesielski CJ; Green P; Foxwell BM; Feldmann M
Arthritis Rheum; 2002 Jan; 46(1):31-41. PubMed ID: 11822409
[TBL] [Abstract][Full Text] [Related]
36. Insulin-induced Drosophila S6 kinase activation requires phosphoinositide 3-kinase and protein kinase B.
Lizcano JM; Alrubaie S; Kieloch A; Deak M; Leevers SJ; Alessi DR
Biochem J; 2003 Sep; 374(Pt 2):297-306. PubMed ID: 12841848
[TBL] [Abstract][Full Text] [Related]
37. Induction of genes involved in cell cycle progression by interleukin-4.
McDonald C; Vanscoy S; Hearing P; Reich NC
J Interferon Cytokine Res; 2004 Dec; 24(12):729-38. PubMed ID: 15684740
[TBL] [Abstract][Full Text] [Related]
38. Role of class II phosphoinositide 3-kinase in cell signalling.
Falasca M; Maffucci T
Biochem Soc Trans; 2007 Apr; 35(Pt 2):211-4. PubMed ID: 17371240
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies.
Foster JG; Blunt MD; Carter E; Ward SG
Pharmacol Rev; 2012 Oct; 64(4):1027-54. PubMed ID: 23023033
[TBL] [Abstract][Full Text] [Related]
40. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement.
Brachmann SM; Yballe CM; Innocenti M; Deane JA; Fruman DA; Thomas SM; Cantley LC
Mol Cell Biol; 2005 Apr; 25(7):2593-606. PubMed ID: 15767666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
